A
Price
$148.06
Change
+$1.32 (+0.90%)
Updated
Sep 27 closing price
51 days until earnings call
RVTY
Price
$126.06
Change
-$0.28 (-0.22%)
Updated
Sep 27 closing price
31 days until earnings call
Ad is loading...

A vs RVTY

Header iconA vs RVTY Comparison
Open Charts A vs RVTYBanner chart's image
Agilent Technologies
Price$148.06
Change+$1.32 (+0.90%)
Volume$2.21M
CapitalizationN/A
Revvity
Price$126.06
Change-$0.28 (-0.22%)
Volume$680.45K
CapitalizationN/A
View a ticker or compare two or three
A vs RVTY Comparison Chart
Loading...
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
A vs. RVTY commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Buy and RVTY is a StrongBuy.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (A: $138.96 vs. RVTY: $119.74)
Brand notoriety: A and RVTY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 101% vs. RVTY: 69%
Market capitalization -- A: $42.66B vs. RVTY: $12.76B
A [@Medical Specialties] is valued at $42.66B. RVTY’s [@Medical Specialties] market capitalization is $12.76B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.77B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 2 FA rating(s) are green whileRVTY’s FA Score has 2 green FA rating(s).

  • A’s FA Score: 2 green, 3 red.
  • RVTY’s FA Score: 2 green, 3 red.
According to our system of comparison, A is a better buy in the long-term than RVTY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while RVTY’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 5 bearish.
  • RVTY’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, A is a better buy in the short-term than RVTY.

Price Growth

A (@Medical Specialties) experienced а -1.52% price change this week, while RVTY (@Medical Specialties) price change was -2.21% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.24%. For the same industry, the average monthly price growth was +3.13%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

A is expected to report earnings on Nov 18, 2024.

RVTY is expected to report earnings on Oct 29, 2024.

Industries' Descriptions

@Medical Specialties (-0.24% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than RVTY($12.8B). RVTY has higher P/E ratio than A: RVTY (71.72) vs A (34.82). RVTY YTD gains are higher at: 9.760 vs. A (0.298). A has higher annual earnings (EBITDA): 1.69B vs. RVTY (714M). A has less debt than RVTY: A (2.56B) vs RVTY (4.07B). A has higher revenues than RVTY: A (6.74B) vs RVTY (2.75B).
ARVTYA / RVTY
Capitalization42.7B12.8B334%
EBITDA1.69B714M237%
Gain YTD0.2989.7603%
P/E Ratio34.8271.7249%
Revenue6.74B2.75B245%
Total CashN/A1.6B-
Total Debt2.56B4.07B63%
FUNDAMENTALS RATINGS
A vs RVTY: Fundamental Ratings
A
RVTY
OUTLOOK RATING
1..100
2570
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
3173
SMR RATING
1..100
4674
PRICE GROWTH RATING
1..100
5030
P/E GROWTH RATING
1..100
5231
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for RVTY (78) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than RVTY’s over the last 12 months.

A's Profit vs Risk Rating (31) in the Biotechnology industry is somewhat better than the same rating for RVTY (73) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than RVTY’s over the last 12 months.

A's SMR Rating (46) in the Biotechnology industry is in the same range as RVTY (74) in the Medical Specialties industry. This means that A’s stock grew similarly to RVTY’s over the last 12 months.

RVTY's Price Growth Rating (30) in the Medical Specialties industry is in the same range as A (50) in the Biotechnology industry. This means that RVTY’s stock grew similarly to A’s over the last 12 months.

RVTY's P/E Growth Rating (31) in the Medical Specialties industry is in the same range as A (52) in the Biotechnology industry. This means that RVTY’s stock grew similarly to A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARVTY
RSI
ODDS (%)
Bearish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Stochastic
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Momentum
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
MACD
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
TrendWeek
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Advances
ODDS (%)
Bullish Trend about 1 month ago
0%
N/A
Declines
ODDS (%)
Bearish Trend about 2 months ago
0%
Bearish Trend about 2 months ago
63%
BollingerBands
ODDS (%)
Bearish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Aroon
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
View a ticker or compare two or three
Ad is loading...
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been loosely correlated with DHR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if A jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
-2.77%
DHR - A
64%
Loosely correlated
-1.89%
RVTY - A
54%
Loosely correlated
-2.28%
RGEN - A
53%
Loosely correlated
-6.06%
IQV - A
53%
Loosely correlated
-1.09%
CRL - A
52%
Loosely correlated
-2.89%
More

RVTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVTY has been loosely correlated with A. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RVTY jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVTY
1D Price
Change %
RVTY100%
-2.28%
A - RVTY
54%
Loosely correlated
-2.77%
DHR - RVTY
50%
Loosely correlated
-1.89%
BRKR - RVTY
49%
Loosely correlated
-2.19%
ILMN - RVTY
48%
Loosely correlated
-0.87%
IQV - RVTY
48%
Loosely correlated
-1.09%
More